M.J. Ledson

3.1k total citations
51 papers, 1.3k citations indexed

About

M.J. Ledson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, M.J. Ledson has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in M.J. Ledson's work include Cystic Fibrosis Research Advances (29 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Bacterial biofilms and quorum sensing (7 papers). M.J. Ledson is often cited by papers focused on Cystic Fibrosis Research Advances (29 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Bacterial biofilms and quorum sensing (7 papers). M.J. Ledson collaborates with scholars based in United Kingdom, Denmark and Brazil. M.J. Ledson's co-authors include Martin Walshaw, Craig Winstanley, Joanne L. Fothergill, Eilidh Mowat, Malcolm Gallagher, H. Miller, M. Al-Aloul, C. A. Hart, C. A. Hart and Stavroula Panagea and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer Research and Journal of Clinical Microbiology.

In The Last Decade

M.J. Ledson

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J. Ledson United Kingdom 21 852 399 377 186 141 51 1.3k
R. Chiron France 26 1.5k 1.8× 365 0.9× 102 0.3× 347 1.9× 94 0.7× 93 2.1k
Wallace J. Matthews United States 18 497 0.6× 462 1.2× 181 0.5× 153 0.8× 55 0.4× 24 1.2k
Changting Liu China 20 192 0.2× 303 0.8× 300 0.8× 394 2.1× 31 0.2× 43 1.2k
Rosemary Carzino Australia 19 1.9k 2.2× 476 1.2× 250 0.7× 459 2.5× 58 0.4× 40 2.3k
Tiantuo Zhang China 24 243 0.3× 340 0.9× 222 0.6× 543 2.9× 35 0.2× 85 1.6k
Giuseppe Magistro Germany 19 349 0.4× 281 0.7× 128 0.3× 212 1.1× 20 0.1× 83 1.2k
David J. Serisier Australia 20 1.6k 1.9× 544 1.4× 85 0.2× 544 2.9× 38 0.3× 49 2.1k
Laura E. Johnson United States 23 334 0.4× 447 1.1× 286 0.8× 304 1.6× 15 0.1× 68 1.7k
Jacques Sarles France 24 755 0.9× 328 0.8× 61 0.2× 592 3.2× 86 0.6× 41 2.3k
Cara Cassino United States 20 963 1.1× 144 0.4× 108 0.3× 68 0.4× 21 0.1× 40 1.6k

Countries citing papers authored by M.J. Ledson

Since Specialization
Citations

This map shows the geographic impact of M.J. Ledson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Ledson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Ledson more than expected).

Fields of papers citing papers by M.J. Ledson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Ledson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Ledson. The network helps show where M.J. Ledson may publish in the future.

Co-authorship network of co-authors of M.J. Ledson

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Ledson. A scholar is included among the top collaborators of M.J. Ledson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Ledson. M.J. Ledson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balata, Haval, Mamta Ruparel, Emma O’Dowd, et al.. (2021). Analysis of the baseline performance of five UK lung cancer screening programmes. Lung Cancer. 161. 136–140. 33 indexed citations
2.
Fothergill, Joanne L., M.J. Ledson, Martin Walshaw, et al.. (2013). Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients. Journal of Cystic Fibrosis. 12(6). 675–681. 12 indexed citations
3.
Ledson, M.J., et al.. (2013). P11 Tyrosine kinase inhibitor use in pulmonary adenocarcinoma. Thorax. 68(Suppl 3). A79.2–A79.
4.
Mowat, Eilidh, Steve Paterson, Joanne L. Fothergill, et al.. (2011). Pseudomonas aeruginosa Population Diversity and Turnover in Cystic Fibrosis Chronic Infections. American Journal of Respiratory and Critical Care Medicine. 183(12). 1674–1679. 191 indexed citations
5.
Ashish, Abdul, Matthew Shaw, Craig Winstanley, M.J. Ledson, & Martin Walshaw. (2011). Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?. Journal of Cystic Fibrosis. 11(3). 173–179. 41 indexed citations
6.
Glenn, Sheila, et al.. (2010). Self-care and cystic fibrosis: a review of research with adults. Health & Social Care in the Community. 18(6). 653–661. 5 indexed citations
7.
Miller, H., Paul W. Dyce, R. Grainger, et al.. (2009). Mechanisms of glucose intolerance in cystic fibrosis. Diabetic Medicine. 26(6). 582–588. 48 indexed citations
8.
Miller, H., et al.. (2008). Management of cystic fibrosis related diabetes: A survey of UK cystic fibrosis centers. Pediatric Pulmonology. 43(7). 642–647. 19 indexed citations
9.
Fothergill, Joanne L., et al.. (2008). Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat. Thorax. 63(9). 839–840. 30 indexed citations
10.
Miller, H., et al.. (2007). Long-Term Effect of Insulin Treatment in Cystic Fibrosis-Related Diabetes. Respiration. 76(2). 181–186. 69 indexed citations
11.
Al-Aloul, M., M. Jackson, G. H. Bell, M.J. Ledson, & Martin Walshaw. (2006). Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients. Journal of Cystic Fibrosis. 6(1). 41–47. 25 indexed citations
12.
Al-Aloul, M., et al.. (2005). Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES). Journal of Cystic Fibrosis. 4(3). 197–201. 28 indexed citations
13.
Panagea, Stavroula, Craig Winstanley, Martin Walshaw, M.J. Ledson, & C. A. Hart. (2004). Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. Journal of Hospital Infection. 59(2). 102–107. 115 indexed citations
14.
Al-Aloul, M., et al.. (2004). Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatric Pulmonology. 39(1). 15–20. 129 indexed citations
15.
Panagea, Stavroula, et al.. (2003). PCR-Based Detection of a Cystic Fibrosis Epidemic Strain of Pseudomonas Aeruginosa. Molecular Diagnosis. 7(3). 195–200. 21 indexed citations
16.
Gallagher, Malcolm, et al.. (2003). Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis. Journal of Cystic Fibrosis. 2(1). 19–24. 64 indexed citations
17.
Panagea, Stavroula, et al.. (2003). PCR-Based Detection of a Cystic Fibrosis Epidemic Strain of Pseudomonas Aeruginosa. Molecular Diagnosis. 7(3). 195–200. 6 indexed citations
18.
19.
Ledson, M.J., Malcolm Gallagher, C. A. Hart, & Martin Walshaw. (2000). Nebulized heparin inBurkholderia cepaciacolonized adult cystic fibrosis patients. European Respiratory Journal. 17(1). 36–38. 26 indexed citations
20.
Ledson, M.J., Malcolm Gallagher, & M. Walshaw. (1998). Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax. 53(5). 430–432. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Chiron Breakdown of academic impact, for papers by Wallace J. Matthews Breakdown of academic impact, for papers by Changting Liu Breakdown of academic impact, for papers by Rosemary Carzino Breakdown of academic impact, for papers by Tiantuo Zhang Breakdown of academic impact, for papers by Giuseppe Magistro Breakdown of academic impact, for papers by David J. Serisier Breakdown of academic impact, for papers by Laura E. Johnson Breakdown of academic impact, for papers by Jacques Sarles Breakdown of academic impact, for papers by Cara Cassino
Rankless by CCL
2026